Patent details

EP3386541 Title: AQUEOUS PHARMACEUTICAL FORMULATION COMPRISING ANTI-PD-1 ANTIBODY AVELUMAB

Basic Information

Publication number:
EP3386541
PCT Application Number:
EP2016002040
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP168189850
PCT Publication Number:
WO2017097407
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
AQUEOUS PHARMACEUTICAL FORMULATION COMPRISING ANTI-PD-1 ANTIBODY AVELUMAB
French Title of Invention:
FORMULATION PHARMACEUTIQUE AQUEUSE COMPRENANT UN ANTICORPS ANTI-PD-1, L'AVELUMAB
German Title of Invention:
WÄSSRIGE PHARMAZEUTISCHE FORMULIERUNG MIT ANTI-PD-1-ANTIKÖRPER AVELUMAB
SPC Number:

Dates

Filing date:
05/12/2016
Grant date:
08/07/2020
EP Publication Date:
17/10/2018
PCT Publication Date:
15/06/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/07/2020
EP B1 Publication Date:
08/07/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
05/12/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
01/07/2020
 
 

Name:
Merck Patent GmbH
Address:
Frankfurter Strasse 250, 64293 Darmstadt, Germany (DE)

Name:
Pfizer Inc.
Address:
235 East 42nd Street, New York, NY 10017, United States (US)

Inventor

1

Name:
FRATARCANGELI, Silvia
Address:
Italy (IT)

2

Name:
VOSS, Senta
Address:
Germany (DE)

3

Name:
WEIGANDT, Markus
Address:
Germany (DE)

4

Name:
RINALDI, Gianluca
Address:
Italy (IT)

5

Name:
DEL RIO, Alessandra
Address:
Italy (IT)

Priority

Priority Number:
15198233
Priority Date:
07/12/2015
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 39/395; C07K 16/28;

Publication

European Patent Bulletin

1

Issue number:
202028
Publication date:
08/07/2020
Description:
Grant (B1)

2

Issue number:
202033
Publication date:
12/08/2020
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
31/12/2026
Annual Fee Number:
11
Annual Fee Amount:
148 Euro
Expected Payer:
Last Annual Fee Payment Date:
19/11/2025
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
131 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages